Locations
England, UK · London, UK · Mile End, London, UK · Kingston Vale, London SW15, UK
industry
Biotechnology · DeepTech · Health
Size
51-200 employees
Stage
Other
founded in
2019
Alchemab Therapeutics is a biotechnology company focused on harnessing the power of the immune system to develop novel antibody therapeutics for hard-to-treat diseases. Their unique platform identifies naturally occurring protective antibodies from resilient individuals, such as long-term cancer survivors, using advanced deep learning and B cell sequencing techniques. With a strong emphasis on neurodegenerative conditions and oncology, Alchemab is building a diverse pipeline of therapeutics, supported by collaborations with patient groups and academic institutions. The company aims to transform drug discovery by leveraging insights from the immune system to create effective treatments for challenging diseases.
Something looks off?